Eloxx Pharmaceuticals, Inc. (ELOX)
13.56
+0.22
(+1.65%)
USD |
OTCM |
Oct 28, 11:42
Eloxx Pharmaceuticals Free Cash Flow
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2023 | -17.99M |
| June 30, 2023 | -21.54M |
| March 31, 2023 | -29.22M |
| December 31, 2022 | -31.91M |
| September 30, 2022 | -36.20M |
| June 30, 2022 | -36.86M |
| March 31, 2022 | -36.91M |
| December 31, 2021 | -35.09M |
| September 30, 2021 | -29.81M |
| June 30, 2021 | -27.41M |
| March 31, 2021 | -23.93M |
| December 31, 2020 | -28.17M |
| September 30, 2020 | -32.76M |
| June 30, 2020 | -38.84M |
| March 31, 2020 | -42.15M |
| December 31, 2019 | -39.43M |
| September 30, 2019 | -39.34M |
| June 30, 2019 | -36.12M |
| March 31, 2019 | -35.05M |
| December 31, 2018 | -31.60M |
| September 30, 2018 | -22.95M |
| June 30, 2018 | -15.22M |
| March 31, 2018 | -7.108M |
| June 30, 2017 | -1.928M |
| March 31, 2017 | -2.134M |
| Date | Value |
|---|---|
| December 31, 2016 | -2.567M |
| September 30, 2016 | -3.118M |
| June 30, 2016 | -3.676M |
| March 31, 2016 | -4.970M |
| December 31, 2015 | -5.721M |
| September 30, 2015 | -6.462M |
| June 30, 2015 | -7.604M |
| March 31, 2015 | -7.032M |
| December 31, 2014 | -7.154M |
| September 30, 2014 | -6.957M |
| June 30, 2014 | -5.496M |
| March 31, 2014 | -5.140M |
| December 31, 2013 | -5.322M |
| September 30, 2013 | -4.462M |
| June 30, 2013 | -4.432M |
| March 31, 2013 | -4.566M |
| December 31, 2012 | -3.762M |
| September 30, 2012 | -4.401M |
| June 30, 2012 | -4.836M |
| March 31, 2012 | -4.895M |
| December 31, 2011 | -5.27M |
| September 30, 2011 | -5.431M |
| June 30, 2011 | -5.820M |
| March 31, 2011 | -7.306M |
| December 31, 2010 | -6.589M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Filana Therapeutics, Inc. | -29.30M |
| CorMedix, Inc. | 250.11M |
| Breakthrough Chemistry, Inc. | -0.0066M |
| BioStem Technologies, Inc. | -8.832M |
| Cardiac Biotech Solutions, Inc. | -0.6874M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.789M |
| Cash from Financing (Quarterly) | 60.39M |
| Free Cash Flow Per Share (Quarterly) | -0.7054 |
| Free Cash Flow to Equity (Quarterly) | -4.789M |
| Free Cash Flow to Firm (Quarterly) | -4.781M |
| Free Cash Flow Yield | -37.20% |